A rapid microneutralization test for antibody determination and serodiagnosis of human coronavirus OC43 infections

G. Gerna, P. M. Cereda, M. G. Revello

Research output: Contribution to journalArticle

Abstract

The only test so far introduced in a cell culture system for the determination of neutralizing antibody to human Coronavirus OC43 is based upon a neutralization-hemadsorption procedure, which does not seem to be reliable enough, since OC43-infected cell cultures do not present a true hemadsorption, but only a false hemadsorption or pseudohemadsorption. Using a cell culture-adapted strain of Coronavirus OC43, a microneutralization (MN) test was set up. Based upon determination of the hemagglutinating activity of the virus, the test gives results as early as 24 h after inoculation of cell cultures with virus-serum mixtures. Three groups of sera (from leukemic, non-leukemic children and adults) have been examined for antibody determination. Furthermore, 104 paired sera from the same groups of subjects have been tested for diagnosis of OC43 infection (or reinfection). Results have been compared with those obtained by hemagglutination-inhibition (HAI), using a cell culture prepared antigen, and the indirect immunoperoxidase antibody technique (IPA). The MN test appears to detect a slightly lower number of positive sera compared to the other two tests. However, it appears much more sensitive in detecting seroconversions (20 cases versus 10 detected by HAI and 16 by IPA). In 16 cases of seroconversion in children, the MN titer in the first serum was consistently ≤1:20. However, in adults seroconversion was observed in three cases with an initial MN antibody titer of 1:80. Neutralizing antibody, when present at a low titer, does not protect against reinfections. The new MN test offers a significant addition to techniques now available for serological diagnosis of human coronavirus OC43 infections.

Original languageEnglish
Pages (from-to)331-344
Number of pages14
JournalMicrobiologica
Volume2
Issue number4
Publication statusPublished - 1979

Fingerprint

Human Coronavirus OC43
Coronavirus Infections
Serologic Tests
Hemadsorption
Cell Culture Techniques
Antibodies
Serum
Hemagglutination
Neutralizing Antibodies
Immunoenzyme Techniques
Viruses
Coronavirus
Antigens
Infection
Seroconversion

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology

Cite this

A rapid microneutralization test for antibody determination and serodiagnosis of human coronavirus OC43 infections. / Gerna, G.; Cereda, P. M.; Revello, M. G.

In: Microbiologica, Vol. 2, No. 4, 1979, p. 331-344.

Research output: Contribution to journalArticle

@article{b562769f13b44994bb2c57951571d38d,
title = "A rapid microneutralization test for antibody determination and serodiagnosis of human coronavirus OC43 infections",
abstract = "The only test so far introduced in a cell culture system for the determination of neutralizing antibody to human Coronavirus OC43 is based upon a neutralization-hemadsorption procedure, which does not seem to be reliable enough, since OC43-infected cell cultures do not present a true hemadsorption, but only a false hemadsorption or pseudohemadsorption. Using a cell culture-adapted strain of Coronavirus OC43, a microneutralization (MN) test was set up. Based upon determination of the hemagglutinating activity of the virus, the test gives results as early as 24 h after inoculation of cell cultures with virus-serum mixtures. Three groups of sera (from leukemic, non-leukemic children and adults) have been examined for antibody determination. Furthermore, 104 paired sera from the same groups of subjects have been tested for diagnosis of OC43 infection (or reinfection). Results have been compared with those obtained by hemagglutination-inhibition (HAI), using a cell culture prepared antigen, and the indirect immunoperoxidase antibody technique (IPA). The MN test appears to detect a slightly lower number of positive sera compared to the other two tests. However, it appears much more sensitive in detecting seroconversions (20 cases versus 10 detected by HAI and 16 by IPA). In 16 cases of seroconversion in children, the MN titer in the first serum was consistently ≤1:20. However, in adults seroconversion was observed in three cases with an initial MN antibody titer of 1:80. Neutralizing antibody, when present at a low titer, does not protect against reinfections. The new MN test offers a significant addition to techniques now available for serological diagnosis of human coronavirus OC43 infections.",
author = "G. Gerna and Cereda, {P. M.} and Revello, {M. G.}",
year = "1979",
language = "English",
volume = "2",
pages = "331--344",
journal = "Microbiologica",
issn = "0391-5352",
publisher = "Luigi Ponzio e figlio Editori",
number = "4",

}

TY - JOUR

T1 - A rapid microneutralization test for antibody determination and serodiagnosis of human coronavirus OC43 infections

AU - Gerna, G.

AU - Cereda, P. M.

AU - Revello, M. G.

PY - 1979

Y1 - 1979

N2 - The only test so far introduced in a cell culture system for the determination of neutralizing antibody to human Coronavirus OC43 is based upon a neutralization-hemadsorption procedure, which does not seem to be reliable enough, since OC43-infected cell cultures do not present a true hemadsorption, but only a false hemadsorption or pseudohemadsorption. Using a cell culture-adapted strain of Coronavirus OC43, a microneutralization (MN) test was set up. Based upon determination of the hemagglutinating activity of the virus, the test gives results as early as 24 h after inoculation of cell cultures with virus-serum mixtures. Three groups of sera (from leukemic, non-leukemic children and adults) have been examined for antibody determination. Furthermore, 104 paired sera from the same groups of subjects have been tested for diagnosis of OC43 infection (or reinfection). Results have been compared with those obtained by hemagglutination-inhibition (HAI), using a cell culture prepared antigen, and the indirect immunoperoxidase antibody technique (IPA). The MN test appears to detect a slightly lower number of positive sera compared to the other two tests. However, it appears much more sensitive in detecting seroconversions (20 cases versus 10 detected by HAI and 16 by IPA). In 16 cases of seroconversion in children, the MN titer in the first serum was consistently ≤1:20. However, in adults seroconversion was observed in three cases with an initial MN antibody titer of 1:80. Neutralizing antibody, when present at a low titer, does not protect against reinfections. The new MN test offers a significant addition to techniques now available for serological diagnosis of human coronavirus OC43 infections.

AB - The only test so far introduced in a cell culture system for the determination of neutralizing antibody to human Coronavirus OC43 is based upon a neutralization-hemadsorption procedure, which does not seem to be reliable enough, since OC43-infected cell cultures do not present a true hemadsorption, but only a false hemadsorption or pseudohemadsorption. Using a cell culture-adapted strain of Coronavirus OC43, a microneutralization (MN) test was set up. Based upon determination of the hemagglutinating activity of the virus, the test gives results as early as 24 h after inoculation of cell cultures with virus-serum mixtures. Three groups of sera (from leukemic, non-leukemic children and adults) have been examined for antibody determination. Furthermore, 104 paired sera from the same groups of subjects have been tested for diagnosis of OC43 infection (or reinfection). Results have been compared with those obtained by hemagglutination-inhibition (HAI), using a cell culture prepared antigen, and the indirect immunoperoxidase antibody technique (IPA). The MN test appears to detect a slightly lower number of positive sera compared to the other two tests. However, it appears much more sensitive in detecting seroconversions (20 cases versus 10 detected by HAI and 16 by IPA). In 16 cases of seroconversion in children, the MN titer in the first serum was consistently ≤1:20. However, in adults seroconversion was observed in three cases with an initial MN antibody titer of 1:80. Neutralizing antibody, when present at a low titer, does not protect against reinfections. The new MN test offers a significant addition to techniques now available for serological diagnosis of human coronavirus OC43 infections.

UR - http://www.scopus.com/inward/record.url?scp=0018601213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018601213&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0018601213

VL - 2

SP - 331

EP - 344

JO - Microbiologica

JF - Microbiologica

SN - 0391-5352

IS - 4

ER -